Skip to main content
. 2022 Jan 31;16:17534666211066064. doi: 10.1177/17534666211066064

Figure 4.

Figure 4.

MET signaling adaptors and mediators, as well as signaling pathways are depicted. Therapeutic intervention strategies to block and inhibit MET receptor oncogenic signaling cascade include blocking ligand-receptor interaction, preventing receptor dimerization, blocking MET kinase intrinsic activity, and inhibiting specific downstream signal transducers. DAG, diacylglycerol; HGF, hepatocyte growth factor; IP3, inositol triphosphate; PIP3, phosphatidylinositol (3,4,5)-triphosphate.